vs
CSG SYSTEMS INTERNATIONAL INC（CSGS）とEnhabit, Inc.（EHAB）の財務データ比較。上の社名をクリックして会社を切り替えられます
CSG SYSTEMS INTERNATIONAL INCの直近四半期売上が大きい（$323.1M vs $270.4M、Enhabit, Inc.の約1.2倍）。CSG SYSTEMS INTERNATIONAL INCの純利益率が高く（2.2% vs -14.3%、差は16.5%）。Enhabit, Inc.の前年同期比売上増加率が高い（4.7% vs 2.0%）。CSG SYSTEMS INTERNATIONAL INCの直近四半期フリーキャッシュフローが多い（$55.8M vs $3.3M）。過去8四半期でCSG SYSTEMS INTERNATIONAL INCの売上複合成長率が高い（4.6% vs 1.5%）
中国南玻集団股フン有限公司は中国最大級の建築用ガラスメーカーで、浮きガラス、建築用ガラス、ディスプレイ用ガラス、自動車用ガラス、コーティングガラス、鏡、カラーフィルターガラス、太陽光発電用ガラス、省エネガラスなど多種多様なガラス製品の製造・販売を手がけています。
Enhabit, Inc.はアメリカ合衆国テキサス州ダラスに本拠を置く在宅医療・終末期ケアサービスプロバイダーです。現在34州に255箇所の在宅医療拠点と110箇所の終末期ケア拠点を展開し、テキサス、アラバマ、フロリダ、ジョージアなどで事業を集中しています。米国で4番目に大きい在宅医療事業者であり、終末期ケア分野でも有数の事業者で、2022年にEncompass Healthから同事業がスピンオフして設立されました。
CSGS vs EHAB — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $323.1M | $270.4M |
| 純利益 | $7.0M | $-38.7M |
| 粗利率 | 50.0% | — |
| 営業利益率 | 9.0% | -12.3% |
| 純利益率 | 2.2% | -14.3% |
| 売上前年比 | 2.0% | 4.7% |
| 純利益前年比 | -79.7% | 15.9% |
| EPS（希薄化後） | $0.24 | $-0.76 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $323.1M | $270.4M | ||
| Q3 25 | $303.6M | $263.6M | ||
| Q2 25 | $297.1M | $266.1M | ||
| Q1 25 | $299.5M | $259.9M | ||
| Q4 24 | $316.7M | $258.2M | ||
| Q3 24 | $295.1M | $253.6M | ||
| Q2 24 | $290.3M | $260.6M | ||
| Q1 24 | $295.1M | $262.4M |
| Q4 25 | $7.0M | $-38.7M | ||
| Q3 25 | $20.5M | $11.1M | ||
| Q2 25 | $12.3M | $5.2M | ||
| Q1 25 | $16.1M | $17.8M | ||
| Q4 24 | $34.5M | $-46.0M | ||
| Q3 24 | $19.1M | $-110.2M | ||
| Q2 24 | $13.8M | $-200.0K | ||
| Q1 24 | $19.5M | $200.0K |
| Q4 25 | 50.0% | — | ||
| Q3 25 | 48.1% | — | ||
| Q2 25 | 49.5% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | 51.3% | — | ||
| Q3 24 | 49.4% | — | ||
| Q2 24 | 47.3% | — | ||
| Q1 24 | 46.5% | — |
| Q4 25 | 9.0% | -12.3% | ||
| Q3 25 | 10.0% | 6.4% | ||
| Q2 25 | 10.0% | 6.3% | ||
| Q1 25 | 9.8% | 6.1% | ||
| Q4 24 | 13.4% | -16.0% | ||
| Q3 24 | 10.8% | -38.6% | ||
| Q2 24 | 8.8% | 4.3% | ||
| Q1 24 | 10.8% | 4.9% |
| Q4 25 | 2.2% | -14.3% | ||
| Q3 25 | 6.7% | 4.2% | ||
| Q2 25 | 4.1% | 2.0% | ||
| Q1 25 | 5.4% | 6.8% | ||
| Q4 24 | 10.9% | -17.8% | ||
| Q3 24 | 6.5% | -43.5% | ||
| Q2 24 | 4.8% | -0.1% | ||
| Q1 24 | 6.6% | 0.1% |
| Q4 25 | $0.24 | $-0.76 | ||
| Q3 25 | $0.73 | $0.22 | ||
| Q2 25 | $0.44 | $0.10 | ||
| Q1 25 | $0.57 | $0.35 | ||
| Q4 24 | $1.20 | $-0.92 | ||
| Q3 24 | $0.67 | $-2.20 | ||
| Q2 24 | $0.48 | $0.00 | ||
| Q1 24 | $0.68 | $0.01 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $180.0M | $43.6M |
| 総負債低いほど良い | $539.5M | $426.0M |
| 株主資本純資産 | $283.7M | $534.0M |
| 総資産 | $1.5B | $1.2B |
| 負債/資本比率低いほどレバレッジが低い | 1.90× | 0.80× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $180.0M | $43.6M | ||
| Q3 25 | $158.4M | $56.9M | ||
| Q2 25 | $145.9M | $37.1M | ||
| Q1 25 | $136.0M | $39.5M | ||
| Q4 24 | $161.8M | $28.4M | ||
| Q3 24 | $118.4M | $45.7M | ||
| Q2 24 | $110.4M | $28.5M | ||
| Q1 24 | $120.8M | $36.5M |
| Q4 25 | $539.5M | $426.0M | ||
| Q3 25 | $538.6M | $441.5M | ||
| Q2 25 | $537.8M | $456.9M | ||
| Q1 25 | $537.6M | $467.3M | ||
| Q4 24 | $538.5M | $492.6M | ||
| Q3 24 | $539.5M | $502.9M | ||
| Q2 24 | $540.5M | $512.7M | ||
| Q1 24 | $541.5M | $526.7M |
| Q4 25 | $283.7M | $534.0M | ||
| Q3 25 | $289.5M | $566.8M | ||
| Q2 25 | $290.7M | $552.4M | ||
| Q1 25 | $283.1M | $543.2M | ||
| Q4 24 | $282.6M | $523.5M | ||
| Q3 24 | $288.4M | $566.1M | ||
| Q2 24 | $273.3M | $674.3M | ||
| Q1 24 | $269.3M | $672.3M |
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.5B | $1.2B | ||
| Q2 25 | $1.4B | $1.2B | ||
| Q1 25 | $1.4B | $1.2B | ||
| Q4 24 | $1.5B | $1.2B | ||
| Q3 24 | $1.4B | $1.3B | ||
| Q2 24 | $1.4B | $1.4B | ||
| Q1 24 | $1.3B | $1.4B |
| Q4 25 | 1.90× | 0.80× | ||
| Q3 25 | 1.86× | 0.78× | ||
| Q2 25 | 1.85× | 0.83× | ||
| Q1 25 | 1.90× | 0.86× | ||
| Q4 24 | 1.91× | 0.94× | ||
| Q3 24 | 1.87× | 0.89× | ||
| Q2 24 | 1.98× | 0.76× | ||
| Q1 24 | 2.01× | 0.78× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $59.2M | $4.4M |
| フリーキャッシュフロー営業CF - 設備投資 | $55.8M | $3.3M |
| FCFマージンFCF / 売上 | 17.3% | 1.2% |
| 設備投資強度設備投資 / 売上 | 1.1% | 0.4% |
| キャッシュ転換率営業CF / 純利益 | 8.46× | — |
| 直近12ヶ月FCF直近4四半期 | $141.4M | $65.8M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $59.2M | $4.4M | ||
| Q3 25 | $47.9M | $37.8M | ||
| Q2 25 | $37.3M | $10.6M | ||
| Q1 25 | $11.5M | $17.9M | ||
| Q4 24 | $82.5M | $-4.1M | ||
| Q3 24 | $39.5M | $28.4M | ||
| Q2 24 | $43.1M | $9.6M | ||
| Q1 24 | $-29.4M | $17.3M |
| Q4 25 | $55.8M | $3.3M | ||
| Q3 25 | $43.9M | $36.2M | ||
| Q2 25 | $34.6M | $8.7M | ||
| Q1 25 | $7.1M | $17.6M | ||
| Q4 24 | $76.6M | $-4.7M | ||
| Q3 24 | $32.0M | $27.7M | ||
| Q2 24 | $38.8M | $8.9M | ||
| Q1 24 | $-34.1M | $15.5M |
| Q4 25 | 17.3% | 1.2% | ||
| Q3 25 | 14.5% | 13.7% | ||
| Q2 25 | 11.6% | 3.3% | ||
| Q1 25 | 2.4% | 6.8% | ||
| Q4 24 | 24.2% | -1.8% | ||
| Q3 24 | 10.8% | 10.9% | ||
| Q2 24 | 13.4% | 3.4% | ||
| Q1 24 | -11.6% | 5.9% |
| Q4 25 | 1.1% | 0.4% | ||
| Q3 25 | 1.3% | 0.6% | ||
| Q2 25 | 0.9% | 0.7% | ||
| Q1 25 | 1.5% | 0.1% | ||
| Q4 24 | 1.9% | 0.2% | ||
| Q3 24 | 2.5% | 0.3% | ||
| Q2 24 | 1.5% | 0.3% | ||
| Q1 24 | 1.6% | 0.7% |
| Q4 25 | 8.46× | — | ||
| Q3 25 | 2.34× | 3.41× | ||
| Q2 25 | 3.04× | 2.04× | ||
| Q1 25 | 0.71× | 1.01× | ||
| Q4 24 | 2.39× | — | ||
| Q3 24 | 2.07× | — | ||
| Q2 24 | 3.12× | — | ||
| Q1 24 | -1.51× | 86.50× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CSGS
| Software As A Service And Related Solutions | $287.2M | 89% |
| License And Service | $22.6M | 7% |
| Maintenance | $13.3M | 4% |
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
